This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.

  80R2829 JTS-F
 
  By: Thompson H.J.R. No. 43
 
 
 
   
 
 
A JOINT RESOLUTION
proposing a constitutional amendment establishing the Texas
Institute for Regenerative Medicine, authorizing the issuance of
bonds for the purposes of the institute, and prohibiting the
legislature from prohibiting stem cell research.
       BE IT RESOLVED BY THE LEGISLATURE OF THE STATE OF TEXAS:
       SECTION 1.  Article XVI, Texas Constitution, is amended by
adding Sections 73 and 74 to read as follows:
       Sec. 73.  (a)  The legislature shall establish the Texas
Institute for Regenerative Medicine to:
             (1)  make grants and loans to institutions of higher
education and advanced medical research facilities in this state
for:
                   (A)  stem cell research;
                   (B)  facilities for stem cell research; and
                   (C)  other vital research opportunities to
develop therapies, protocols, or medical procedures that will
result in, as speedily as possible, the cure for, or substantial
mitigation of, major diseases, injuries, and orphan diseases;
             (2)  support institutions of higher education and
advanced medical research facilities in this state in all stages of
the process of developing cures using regenerative medicine, from
laboratory research through successful clinical trials; and
             (3)  establish the appropriate regulatory standards
and oversight bodies for regenerative medicine research and
facilities development.
       (b)  Money authorized for, or made available to, the
institute may not be used for research involving human reproductive
cloning.
       (c)  The Texas Public Finance Authority shall issue and sell
general obligation bonds of the State of Texas in an aggregate
amount of $900 million over a six-year period. The Texas Public
Finance Authority shall issue bonds in the amount of $112.5 million
per year in the first three years and $187.5 million per year in the
subsequent three years.
       (d)  The proceeds from the sale of the bonds shall be
deposited in the stem cell research account in the state treasury or
its successor account to be used by the Texas Institute for
Regenerative Medicine without further appropriation for the
purposes of this section.
       (e)  The expenses incurred in connection with the issuance of
the bonds and the costs of administering this section may be paid
from money in the stem cell research account.
       (f)  Bonds authorized under this section are a general
obligation of the state. While any of the bonds or interest on the
bonds is outstanding and unpaid, there is appropriated out of the
first money coming into the treasury in each fiscal year, not
otherwise appropriated by this constitution, the amount sufficient
to pay the principal of and interest on the bonds that mature or
become due during the fiscal year, less any amounts in the interest
and sinking accounts at the close of the preceding fiscal year that
are pledged to payment of the bonds or interest.
       (g)  Notwithstanding any other provision of this
constitution, the institute, which is established in state
government, may use money from the bonds issued under Subsection
(c) and federal or private grants to fund the institute's:
             (1)  operations;
             (2)  medical and scientific research, including
therapy development through clinical trials; and
             (3)  facilities.
       Sec. 74.  (a)  In this section:
             (1)  "Pluripotent stem cells" means cells that are
capable of self-renewal and have broad potential to differentiate
into multiple adult cell types.
             (2)  "Progenitor cells" are multipotent or precursor
cells that are partially differentiated but retain the ability to
divide and give rise to differentiated cells.
       (b)  The legislature may not prohibit the performance of stem
cell research, including research involving:
             (1)  adult stem cells;
             (2)  cord blood stem cells;
             (3)  pluripotent stem cells derived from:
                   (A)  somatic cell nuclear transfer; or
                   (B)  surplus products of in vitro fertilization
treatments, if the products are donated under appropriate informed
consent procedures; and
             (4)  progenitor cells.
       SECTION 2.  This proposed constitutional amendment shall be
submitted to the voters at an election to be held November 6, 2007.
The ballot shall be printed to permit voting for or against the
proposition: "The constitutional amendment establishing the Texas
Institute for Regenerative Medicine, authorizing the issuance of
bonds for the purposes of the institute, and prohibiting the
legislature from banning stem cell research."